Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000320017-25-000030
Filing Date
2025-05-08
Accepted
2025-05-08 16:14:15
Documents
85
Period of Report
2025-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q lsta-20250331.htm   iXBRL 10-Q 861865
2 EX-31.1 lsta-ex311_20250331.htm EX-31.1 9595
3 EX-31.2 lsta-ex312_20250331.htm EX-31.2 9637
4 EX-32.1 lsta-ex321_20250331.htm EX-32.1 6846
5 EX-32.2 lsta-ex322_20250331.htm EX-32.2 6923
11 lsta-20250331_g1.jpg GRAPHIC 195428
  Complete submission text file 0000320017-25-000030.txt   6883290

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT lsta-20250331.xsd EX-101.SCH 50991
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT lsta-20250331_cal.xml EX-101.CAL 58885
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT lsta-20250331_def.xml EX-101.DEF 192868
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT lsta-20250331_lab.xml EX-101.LAB 666804
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT lsta-20250331_pre.xml EX-101.PRE 451615
88 EXTRACTED XBRL INSTANCE DOCUMENT lsta-20250331_htm.xml XML 816447
Mailing Address 110 ALLEN ROAD SECOND FLOOR BASKING RIDGE NJ 07920
Business Address 110 ALLEN ROAD SECOND FLOOR BASKING RIDGE NJ 07920 908-229-2590
LISATA THERAPEUTICS, INC. (Filer) CIK: 0000320017 (see all company filings)

EIN.: 222343568 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33650 | Film No.: 25926271
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)